Charles River Laboratories International, Inc. (NYSE:CRL) Given Consensus Rating of Moderate Buy by Brokerages

Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has been assigned an average rating of “Moderate Buy” from the eleven ratings firms that are covering the company, Marketbeat reports. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average […]

Related Keywords

United States ,Sugarloaf ,Nova Scotia ,Canada ,Birgit Girshick ,Asia Pacific ,Richardf Wallman ,Jpmorgan Chase Co ,Morgan Stanley ,Research Models ,Charles River Laboratories International Trading ,Manufacturing Solutions ,Charles River Laboratories International ,Analyst Recommendations For Charles River Laboratories International ,Sugarloaf Wealth Management ,Banking Corp ,Charles River Laboratories International Company Profile ,Charles River Laboratories International Inc ,Mitsubishi Ufj ,Envestnet Asset Management Inc ,Get Free Report ,River Laboratories International ,Director Richard ,North Carolina ,Asset Management ,Management Fondsmaeglerselskab ,Wealth Management ,Get Free ,Safety Assessment ,Charles River Laboratories International Daily ,Nyse Crl ,Crl ,Medical ,15986410 ,Ratings ,Consensus ,